Home > Press > Strem Adds Biocatalysis Offerings with GoNano Technologies’ Enzymatic Flow Reactor
Nanospring enzymatic flow reactor (a) and SEM image of catalyst support disk (b). |
Abstract:
Strem Chemicals, Inc., a manufacturer of specialty chemicals for research and development, is pleased to announce the addition of Enzymatic Flow Reactors for Biocatalysis applications, through its partnership with GoNano Technologies.
The GoNano Technologies' Enzymatic Flow Reactor (EFR) provides a platform for enzyme immobilization in a flow reactor configuration. Each reactor contains 200 permeable catalyst support disks coated with GoNano's proprietary silica Nanosprings™, which have been functionalized for enzyme attachment. Each 0.25" x 2.5" reactor contains in excess of 25 m2 of surface area for enzyme immobilization.
Because the enzyme remains in the reactor and does not become mixed with the reactants the enzyme can be reused without subsequent separation from product. Also, the reaction product is continuously separated from the enzyme minimizing product inhibition. A further advantage is that immobilized enzymes often display significant increases in stability over free enzymes in solution.
"Strem Chemicals' reputation for quality, experience and customer care combined with GoNano Technologies innovative Nanospring-based products bring enormous potential" said Tim Kinkeade, CEO of GoNano Technologies. Dr. David Hyatt, Biocatalyst Engineer adds, "The EFR technology leverages the inherent material characteristics of the Nanosprings including their high surface area (>350 m2/g), the robust bond of the Nanosprings to the catalyst support disk, and a surface chemistry compatible with biomolecules."
"We are pleased to be working with GoNano Technologies as the development of biocatalysis is moving forward rapidly and leading to the widespread adoption of Green Chemistry methods. Our customers expect Strem to provide cutting-edge research products and the addition of Enzymatic Flow Reactors - for Biocatalysis applications confirms our commitment to meet their needs," said Strem's Chief Operating Officer Dr. Ephraim S. Honig.
####
About GoNano Technologies, Inc.
GoNano Technologies, Inc produces high surface area materials for transformational solutions in pollution control, biocatalysis, catalysis, composites and sensory technologies. GoNano’s products and domain expertise leverage our ability to integrate bulk substrates with proprietary silica Nanospring matrices. To better understand how Nanosprings can be integrated into your products or processes, please call 208.892.2000 or visit our website at www.gonano-technologies.com.
About Strem Chemicals, Inc.
Strem Chemicals, Inc., established in 1964, is a privately held manufacturer and marketer of specialty chemicals of high purity. Strem’s key products include catalysts, ligands, organometallics, metal carbonyls and nanomaterials. Its products are used for research and development and commercial scale applications, especially in the pharmaceutical, microelectronics, chemicals and petrochemicals industries. Strem Chemicals also provides custom synthesis, process development and cGMP manufacturing services. For more information visit www.strem.com.
For more information, please click here
Contacts:
Tim Kinkeade
GoNano Technologies, Inc
USA
Phone: 208.892.2000
Fax: 208.892.2001
Copyright © GoNano Technologies, Inc.
If you have a comment, please Contact us.Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
Related News Press |
News and information
Beyond wires: Bubble technology powers next-generation electronics:New laser-based bubble printing technique creates ultra-flexible liquid metal circuits November 8th, 2024
Nanoparticle bursts over the Amazon rainforest: Rainfall induces bursts of natural nanoparticles that can form clouds and further precipitation over the Amazon rainforest November 8th, 2024
Nanotechnology: Flexible biosensors with modular design November 8th, 2024
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Announcements
Nanotechnology: Flexible biosensors with modular design November 8th, 2024
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Turning up the signal November 8th, 2024
Nanofibrous metal oxide semiconductor for sensory face November 8th, 2024
Tools
Turning up the signal November 8th, 2024
Quantum researchers cause controlled ‘wobble’ in the nucleus of a single atom September 13th, 2024
Faster than one pixel at a time – new imaging method for neutral atomic beam microscopes developed by Swansea researchers August 16th, 2024
Alliances/Trade associations/Partnerships/Distributorships
Chicago Quantum Exchange welcomes six new partners highlighting quantum technology solutions, from Chicago and beyond September 23rd, 2022
University of Illinois Chicago joins Brookhaven Lab's Quantum Center June 10th, 2022
The latest news from around the world, FREE | ||
Premium Products | ||
Only the news you want to read!
Learn More |
||
Full-service, expert consulting
Learn More |
||